HBsAg (% of all 720 samples obtained)
|
113 (15.7)
|
18 (2.5)
|
131 (18.2)
|
7 (1.0)
|
1 (0.1)
|
8 (1.1)
|
120 (16.7)
|
19 (2.6)
|
139 (19.3)
|
HBeAga
(% of 132 HBsAg positive samples)
|
27 (20.5)
|
4 (3.0)
|
31 (23.5)
|
1 (0.8)
|
0
|
1 (0.8)
|
28 (21.2)
|
4 (3.0)
|
32 (24.2)
|
Anti-HBeb
(% of 131 HBsAg positive samples)
|
82 (62.6)
|
14 (10.7)
|
96 (73.3)
|
5 (3.8)
|
1 (0.8)
|
6 (4.6)
|
87 (66.4)
|
15 (11.4)
|
102 (77.9)
|
HBV DNA and HBeAg (% of HBeAg positive samples)
|
26 (96.3)
|
4 (100)
|
30 (96.8)
|
1 (100)
|
0
|
1 (100)
|
27 (96.4)
|
4 (100)
|
31 (96.9)
|
HBV DNA and anti-HBe (% of anti-HBe positive samples)
|
40 (48.8)
|
11 (78.6)
|
51 (53.1)
|
2 (40)
|
0
|
2 (33)
|
42 (48.3)
|
11 (73.3)
|
53 (52.0)
|
All with HBV DNA (% of 139HBsAg positive samples)
|
67 (48.2)
|
15 (10.8)
|
82 (59.0)
|
3 (2.2)
|
0
|
3 (2.2)
|
70 (50.4)
|
15 (10.8)
|
85 (61.2)
|
Anti-HBs and anti-HBc (% of 581 HBsAg negative)
|
37 (0.6)
|
11 (1.9)
|
48 (8.3)
|
66 (11.4)
|
8 (1.4)
|
74 (12.7)
|
103 (17.7)
|
19 (3.3)
|
122 (21)
|
Anti-HBs lacking anti-HBc (% of 581 HBsAg negative)
|
9 (1.5)
|
3 (0.6)
|
12 (2)
|
11 (1.9)
|
2 (0.3)
|
13 (2.2)
|
20 (3.4)
|
5 (0.9)
|
25 (4.3)
|